Voya Investment Management LLC Checkpoint Therapeutics, Inc. Transaction History

Voya Investment Management LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$2.36 - $3.2 $61,683 - $83,638	-26,137 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$2.6 - $4.16 $11,577 - $18,524	4,453 Added 20.54%	26,137 $82,000
Q4 2020 Feb 16, 2021	BUY	$2.19 - $2.96 $15,452 - $20,885	7,056 Added 48.24%	21,684 $57,000
Q3 2020 Nov 16, 2020	BUY	$1.62 - $4.24 $7,241 - $18,952	4,470 Added 44.0%	14,628 $39,000
Q2 2020 Aug 14, 2020	SELL	$1.19 - $2.27 $10,438 - $19,912	-8,772 Reduced 46.34%	10,158 $20,000
Q4 2019 Feb 14, 2020	BUY	$1.18 - $2.39 $22,337 - $45,242	18,930 New	18,930 $33,000
Q3 2019 Nov 14, 2019	SELL	$2.15 - $3.36 $36,255 - $56,659	-16,863 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$2.75 - $5.0 $46,373 - $84,315	16,863 New	16,863 $51,000

1.91M

Ticker CKPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 85,497,000
Market Cap $351M
Description
Checkpoint Therapeutics, Inc., clinical-stage immunotherapy and targeted oncology company, focuses on the acquisition, development, and commercialization of novel treatments for patients with solid tumor cancers. The company's lead antibody product candidate is Cosibelimab, a fully-human monoclonal antibody of IgG1 subtype that directly binds to...

Get notified when there are updates to the investment portfolio of Voya Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on Voya Investment Management LLC with notifications on news.